Caris Life Sciences (CAI) Total Liabilities (2024 - 2026)

Caris Life Sciences' Total Liabilities history runs 3 years deep, the most recent figure standing at $568.9 million for Q1 2026.

• In Q1 2026, Total Liabilities changed N/A year-over-year to $568.9 million; the TTM figure through Mar 2026 stood at $568.9 million (changed N/A YoY), while the FY2025 annual figure was $548.4 million, down 11.69% from the prior year.
• Total Liabilities for Q1 2026 stood at $568.9 million, up from $548.4 million in the prior quarter.
• The five-year high for Total Liabilities was $620.9 million in Q4 2024, with the low at $502.2 million in Q2 2025.
• The 3-year median for Total Liabilities is $548.4 million (2025), against an average of $549.3 million.
• Peak annual rise in Total Liabilities reached 11.69% in 2025, while the deepest fall reached 11.69% in 2025.
• Caris Life Sciences' Total Liabilities stood at $620.9 million in 2024, then declined by 11.69% to $548.4 million in 2025, then rose by 3.75% to $568.9 million in 2026.
• Business Quant data shows CAI's Total Liabilities at $568.9 million in Q1 2026, $548.4 million in Q4 2025, and $506.2 million in Q3 2025.